David A. Siegel Entasis Therapeutics Holdings Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.45 - $2.27 $244,615 - $382,949
-168,700 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.1 - $3.4 $126,630 - $205,020
-60,300 Reduced 26.33%
168,700 $369,000
Q3 2021

Nov 15, 2021
BUY
$2.27 - $3.77 $149,951 - $249,038
66,058 Added 40.54%
229,000 $765,000
Q2 2021

Aug 16, 2021
BUY
$1.82 - $3.04 $296,554 - $495,343
162,942 New
162,942 $435,000

About Entasis Therapeutics Holdings Inc.

ETTX Quotes by TradingView
  • Ticker ETTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,851,800
  • Market Cap $105M
More about ETTX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email